IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers

Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation Vol. 128; no. 4; pp. 1300 - 1316
Main Authors: Xie, Hong, Tang, Chih-Hang Anthony, Song, Jun H, Mancuso, Anthony, Del Valle, Juan R, Cao, Jin, Xiang, Yan, Dang, Chi V, Lan, Roy, Sanchez, Danielle J, Keith, Brian, Hu, Chih-Chi Andrew, Simon, M Celeste
Format: Journal Article
Language:English
Published: United States American Society for Clinical Investigation 02-04-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1α/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1α RNase activity suppression in vivo. Furthermore, IRE1α inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1α/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers.
AbstractList Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1a (IRE1a)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1a/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1a RNase activity suppression in vivo. Furthermore, IRE1a inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1a/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers.
Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1α/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1α RNase activity suppression in vivo. Furthermore, IRE1α inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1α/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers.
Author Del Valle, Juan R
Tang, Chih-Hang Anthony
Xiang, Yan
Hu, Chih-Chi Andrew
Lan, Roy
Keith, Brian
Sanchez, Danielle J
Dang, Chi V
Song, Jun H
Xie, Hong
Cao, Jin
Mancuso, Anthony
Simon, M Celeste
AuthorAffiliation 3 The Wistar Institute, Philadelphia, Pennsylvania, USA
1 Abramson Family Cancer Research Institute and
4 Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
2 Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
8 Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA
7 Lester and Sue Smith Breast Center, and
6 Department of Molecular and Cellular Biology
5 Department of Chemistry, University of South Florida, Tampa, Florida, USA
AuthorAffiliation_xml – name: 4 Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– name: 7 Lester and Sue Smith Breast Center, and
– name: 1 Abramson Family Cancer Research Institute and
– name: 6 Department of Molecular and Cellular Biology
– name: 8 Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA
– name: 3 The Wistar Institute, Philadelphia, Pennsylvania, USA
– name: 2 Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– name: 5 Department of Chemistry, University of South Florida, Tampa, Florida, USA
Author_xml – sequence: 1
  givenname: Hong
  surname: Xie
  fullname: Xie, Hong
  organization: Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 2
  givenname: Chih-Hang Anthony
  surname: Tang
  fullname: Tang, Chih-Hang Anthony
  organization: The Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 3
  givenname: Jun H
  surname: Song
  fullname: Song, Jun H
  organization: Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 4
  givenname: Anthony
  surname: Mancuso
  fullname: Mancuso, Anthony
  organization: Abramson Family Cancer Research Institute and
– sequence: 5
  givenname: Juan R
  surname: Del Valle
  fullname: Del Valle, Juan R
  organization: Department of Chemistry, University of South Florida, Tampa, Florida, USA
– sequence: 6
  givenname: Jin
  surname: Cao
  fullname: Cao, Jin
  organization: Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA
– sequence: 7
  givenname: Yan
  surname: Xiang
  fullname: Xiang, Yan
  organization: Abramson Family Cancer Research Institute and
– sequence: 8
  givenname: Chi V
  surname: Dang
  fullname: Dang, Chi V
  organization: Abramson Family Cancer Research Institute and
– sequence: 9
  givenname: Roy
  surname: Lan
  fullname: Lan, Roy
  organization: Abramson Family Cancer Research Institute and
– sequence: 10
  givenname: Danielle J
  surname: Sanchez
  fullname: Sanchez, Danielle J
  organization: Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 11
  givenname: Brian
  surname: Keith
  fullname: Keith, Brian
  organization: Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 12
  givenname: Chih-Chi Andrew
  surname: Hu
  fullname: Hu, Chih-Chi Andrew
  organization: The Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 13
  givenname: M Celeste
  surname: Simon
  fullname: Simon, M Celeste
  organization: Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29381485$$D View this record in MEDLINE/PubMed
BookMark eNpdkd1q3DAQhUVJSDbbQJ-gGHqTGzcjS7Klm0JZNsmW_MDSXAutPG4UbMmV7IU8Vl8kzxSHbn7aq7mYwzdnzjkiez54JOQTha-UVsXpj8VKCVnyD2RGhZC5LJjcIzOAguaqYvKQHKV0D0A5F_yAHBaKScqlmJHb1XpJH_9k62uTMK-xR1-jH7LW9a7O7kKHIQ0muZT1MXRhwJSlMW7d1rSZ89nVg82HaHxqQuywzqzxFmP6SPYb0yY83s05uT1b_lxc5Jc356vF98vccoAhRwaN2tAaG1srKmvJ6kKCKivYYCMtcNxwq7g0k9-qAWaFgVIoQYUqOaOCzcm3v9x-3Ezn7eQ8mlb30XUmPuhgnP53492d_hW2WsgpFakmwMkOEMPvEdOgO5cstq3xGMakqVIMoCymEOfky3_S-zBGP72nCxBlpUoJ8Aa0MaQUsXk1Q0E_d6Vfupqkn9-bfxW-lMOeABpUkVA
CitedBy_id crossref_primary_10_1016_j_jpedsurg_2023_02_037
crossref_primary_10_1038_s41467_021_25684_3
crossref_primary_10_1016_j_molmed_2018_05_005
crossref_primary_10_1038_s41392_021_00500_y
crossref_primary_10_1111_bjh_19425
crossref_primary_10_1158_0008_5472_CAN_22_2679
crossref_primary_10_1038_s41388_021_02108_6
crossref_primary_10_1101_cshperspect_a041542
crossref_primary_10_1016_j_trecan_2022_06_006
crossref_primary_10_1126_scitranslmed_aar7535
crossref_primary_10_1016_j_chembiol_2023_08_011
crossref_primary_10_1038_s41467_022_30159_0
crossref_primary_10_4049_immunohorizons_2200064
crossref_primary_10_1038_s41568_020_00312_2
crossref_primary_10_3389_fcell_2021_683940
crossref_primary_10_1016_j_tips_2020_11_014
crossref_primary_10_3389_fonc_2020_00562
crossref_primary_10_1016_j_bbrc_2022_04_108
crossref_primary_10_3389_fgene_2022_949314
crossref_primary_10_1172_JCI151591
crossref_primary_10_15252_emmm_201911845
crossref_primary_10_3390_ijms23169113
crossref_primary_10_1016_j_pharmthera_2023_108413
crossref_primary_10_1002_1878_0261_12835
crossref_primary_10_1016_j_jep_2018_05_039
crossref_primary_10_1038_s41401_023_01225_0
crossref_primary_10_1021_acsnano_1c04068
crossref_primary_10_1038_s41388_019_0912_5
crossref_primary_10_3390_ijms24010589
crossref_primary_10_1007_s11523_022_00870_5
crossref_primary_10_1038_s41580_020_0227_y
crossref_primary_10_3390_cancers14215340
crossref_primary_10_1038_s41375_024_02321_8
crossref_primary_10_1093_abbs_gmab131
crossref_primary_10_1016_j_biopha_2020_110069
crossref_primary_10_1016_j_biopha_2022_113741
crossref_primary_10_1074_jbc_RA119_008353
crossref_primary_10_1111_jcmm_16255
crossref_primary_10_1158_0008_5472_CAN_21_1545
crossref_primary_10_3389_fphar_2024_1322557
crossref_primary_10_1016_j_bbcan_2018_05_003
crossref_primary_10_15252_emmm_202114764
crossref_primary_10_1016_j_cmet_2019_07_012
crossref_primary_10_1186_s10020_024_00808_9
crossref_primary_10_1158_2767_9764_CRC_23_0030
crossref_primary_10_3390_ijms21176314
crossref_primary_10_2139_ssrn_4152835
crossref_primary_10_1172_JCI95873
crossref_primary_10_14336_AD_2022_0824
crossref_primary_10_1016_j_isci_2022_105183
crossref_primary_10_1016_j_molcel_2019_10_014
crossref_primary_10_1080_2162402X_2022_2116844
crossref_primary_10_1128_spectrum_02636_23
crossref_primary_10_15252_embr_202152509
crossref_primary_10_1016_j_molcel_2019_09_008
crossref_primary_10_1002_art_41883
crossref_primary_10_1016_j_tips_2024_04_007
crossref_primary_10_1158_2643_3230_BCD_22_0162
crossref_primary_10_1038_s41388_024_02988_4
crossref_primary_10_3390_ijms24065493
crossref_primary_10_1158_0008_5472_CAN_19_3108
crossref_primary_10_1080_14728222_2023_2293746
crossref_primary_10_1021_acs_molpharmaceut_1c00639
crossref_primary_10_1038_s41589_019_0326_2
crossref_primary_10_3390_cancers14102526
crossref_primary_10_5604_01_3001_0011_7381
crossref_primary_10_1016_j_cmet_2022_10_010
crossref_primary_10_1038_s41420_021_00696_6
crossref_primary_10_1039_C9NP00066F
crossref_primary_10_1016_j_trecan_2019_12_001
crossref_primary_10_1084_jem_20201606
crossref_primary_10_1016_j_phrs_2020_105131
crossref_primary_10_3390_cells11081265
crossref_primary_10_1016_j_biopha_2022_112747
crossref_primary_10_1038_s41401_020_00505_3
crossref_primary_10_1016_j_canlet_2018_06_012
crossref_primary_10_1016_j_it_2018_12_001
crossref_primary_10_1158_1535_7163_MCT_20_0127
crossref_primary_10_1016_j_intimp_2020_106930
crossref_primary_10_1186_s13046_020_01702_y
crossref_primary_10_1128_JVI_01229_20
crossref_primary_10_1021_acs_jmedchem_9b00269
crossref_primary_10_3389_fonc_2020_01100
crossref_primary_10_1038_s41589_020_00654_w
crossref_primary_10_1146_annurev_pathol_061020_050135
crossref_primary_10_1038_s41416_020_01119_6
crossref_primary_10_3390_biomedicines9020156
crossref_primary_10_1016_j_csbj_2023_08_009
crossref_primary_10_1016_j_drup_2023_100963
Cites_doi 10.1038/nature21064
10.1038/onc.2008.312
10.1016/j.tcb.2013.06.005
10.1101/cshperspect.a014415
10.1158/1078-0432.CCR-12-3249
10.3945/an.110.000125
10.1101/cshperspect.a014241
10.1101/cshperspect.a014282
10.1016/S0140-6736(11)61177-X
10.1126/science.287.5453.664
10.1038/ncb3266
10.1021/ac202220b
10.1186/gb-2003-4-10-r69
10.1101/cshperspect.a014266
10.1016/j.cmet.2012.09.004
10.1084/jem.192.8.1183
10.1128/MCB.23.21.7448-7459.2003
10.1126/science.1158042
10.1182/blood-2011-07-366633
10.1016/j.ccr.2014.03.015
10.1038/nature07449
10.1016/j.tem.2016.01.001
10.1172/JCI62973
10.1016/j.ccell.2014.11.024
10.1007/s10616-010-9263-3
10.1371/journal.pone.0011621
10.1016/j.cell.2012.03.003
10.1038/nature12138
10.1083/jcb.200903014
10.1038/sj.onc.1211017
10.1073/pnas.1307237110
10.1038/nrm3270
10.1073/pnas.0901230107
10.1016/j.trecan.2016.03.007
10.1172/JCI75836
10.1084/jem.20080809
10.4049/jimmunol.0900953
10.1073/pnas.1115623109
10.1139/o59-099
10.1158/2159-8290.CD-12-0418
10.1016/B978-0-12-385114-7.00004-0
10.1182/blood-2011-11-394346
10.1172/JCI73448
10.1016/j.molcel.2007.06.011
10.1101/gad.198630.112
10.1038/nature13119
10.1073/pnas.1217611110
10.1016/j.cell.2015.06.017
10.1371/journal.pgen.1003664
10.1101/gad.14.11.1390
10.1074/jbc.M112.412783
10.1002/cmdc.200600294
10.1073/pnas.1409778111
10.1016/j.cell.2011.08.017
10.1016/j.cell.2015.05.025
10.1158/2159-8290.CD-14-1507
10.1038/ng1532
10.1371/journal.pone.0033823
10.1016/j.bbrc.2015.05.061
ContentType Journal Article
Copyright Copyright American Society for Clinical Investigation Apr 2018
Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation
Copyright_xml – notice: Copyright American Society for Clinical Investigation Apr 2018
– notice: Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation
DBID NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
S0X
7X8
5PM
DOI 10.1172/JCI95864
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
eLibrary
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest Central Student
ProQuest Central Essentials
SIRS Editorial
elibrary
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
PubMed

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-8238
EndPage 1316
ExternalDocumentID 10_1172_JCI95864
29381485
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA057341
– fundername: NCI NIH HHS
  grantid: P01 CA104838
– fundername: NCI NIH HHS
  grantid: R21 CA199553
– fundername: NCI NIH HHS
  grantid: R01 CA163910
– fundername: NICHD NIH HHS
  grantid: T32 HD083185
– fundername: NCI NIH HHS
  grantid: P30 CA010815
– fundername: NCI NIH HHS
  grantid: R01 CA190860
– fundername: ;
  grantid: CA199553
– fundername: ;
  grantid: CA190860
– fundername: ;
  grantid: N/A
– fundername: ;
  grantid: CA104838
– fundername: ;
  grantid: CA163910
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
3V.
5GY
5RE
5RS
7RV
7X7
88A
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
AEAQA
AENEX
AFCHL
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CS3
D-I
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M0L
M1P
M5~
M7P
NAPCQ
NPM
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
P2P
P6G
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c400t-e30f9b1defcd918d83d2809670bef8c04eb4c948a2937f03c5a06595159643153
IEDL.DBID RPM
ISSN 0021-9738
IngestDate Tue Sep 17 21:24:45 EDT 2024
Fri Oct 25 11:59:27 EDT 2024
Sun Nov 24 01:51:13 EST 2024
Thu Sep 26 17:13:49 EDT 2024
Wed Oct 16 00:51:36 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Oncology
Cell stress
Drug therapy
Therapeutics
Cancer
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c400t-e30f9b1defcd918d83d2809670bef8c04eb4c948a2937f03c5a06595159643153
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9024-2932
0000-0002-5097-5709
OpenAccessLink http://www.jci.org/articles/view/95864/files/pdf
PMID 29381485
PQID 2056796800
PQPubID 42166
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5873889
proquest_miscellaneous_1993006297
proquest_journals_2056796800
crossref_primary_10_1172_JCI95864
pubmed_primary_29381485
PublicationCentury 2000
PublicationDate 2018-04-02
PublicationDateYYYYMMDD 2018-04-02
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-02
  day: 02
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Ann Arbor
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 2018
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B22
B23
B25
B26
B27
B28
B29
B30
B31
B32
B33
B34
B35
B36
B37
B38
B39
B1
Huang (B43) 2013; 3
B4
B5
B6
B8
B9
Zhao (B47)
Gabay (B3) 2014; 4
B40
B41
B42
B44
B45
B46
B48
B49
Schmitz (B16) 2014; 4
B50
Liu (B21) 2017; 8
B51
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B58
B15
B59
McKeown (B7) 2014; 4
B17
B18
B19
Malynn (B2) 2000; 14
B60
Oslowski (B24) 2011; 490
B61
B62
B63
References_xml – ident: B55
  doi: 10.1038/nature21064
– ident: B44
  doi: 10.1038/onc.2008.312
– ident: B12
  doi: 10.1016/j.tcb.2013.06.005
– volume: 3
  issue: 10
  year: 2013
  ident: B43
  article-title: Neuroblastoma and MYCN
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a014415
  contributor:
    fullname: Huang
– ident: B50
  doi: 10.1158/1078-0432.CCR-12-3249
– ident: B51
  doi: 10.3945/an.110.000125
– volume: 4
  issue: 6
  year: 2014
  ident: B3
  article-title: MYC activation is a hallmark of cancer initiation and maintenance
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a014241
  contributor:
    fullname: Gabay
– volume: 4
  issue: 2
  year: 2014
  ident: B16
  article-title: Oncogenic mechanisms in Burkitt lymphoma
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a014282
  contributor:
    fullname: Schmitz
– ident: B27
  doi: 10.1016/S0140-6736(11)61177-X
– ident: B28
  doi: 10.1126/science.287.5453.664
– ident: B22
  doi: 10.1038/ncb3266
– ident: B34
  doi: 10.1021/ac202220b
– ident: B38
  doi: 10.1186/gb-2003-4-10-r69
– volume: 4
  issue: 10
  year: 2014
  ident: B7
  article-title: Therapeutic strategies to inhibit MYC
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a014266
  contributor:
    fullname: McKeown
– ident: B19
  doi: 10.1016/j.cmet.2012.09.004
– ident: B62
  doi: 10.1084/jem.192.8.1183
– ident: B13
  doi: 10.1128/MCB.23.21.7448-7459.2003
– ident: B26
  doi: 10.1126/science.1158042
– ident: B56
  doi: 10.1182/blood-2011-07-366633
– ident: B45
  doi: 10.1016/j.ccr.2014.03.015
– ident: B8
  doi: 10.1038/nature07449
– ident: B31
  doi: 10.1016/j.tem.2016.01.001
– ident: B10
  doi: 10.1172/JCI62973
– ident: B52
  doi: 10.1016/j.ccell.2014.11.024
– ident: B41
  doi: 10.1007/s10616-010-9263-3
– ident: B60
  doi: 10.1371/journal.pone.0011621
– ident: B1
  doi: 10.1016/j.cell.2012.03.003
– ident: B39
  doi: 10.1038/nature12138
– ident: B15
  doi: 10.1083/jcb.200903014
– volume: 8
  year: 2017
  ident: B21
  article-title: A critical role of DDRGK1 in endoplasmic reticulum homoeostasis via regulation of IRE1α stability
  publication-title: Nat Commun
  contributor:
    fullname: Liu
– ident: B59
  doi: 10.1038/sj.onc.1211017
– ident: B53
  doi: 10.1073/pnas.1307237110
– ident: B9
  doi: 10.1038/nrm3270
– ident: B20
  doi: 10.1073/pnas.0901230107
– ident: B46
  doi: 10.1016/j.trecan.2016.03.007
– ident: B63
  doi: 10.1172/JCI75836
– ident: B18
  doi: 10.1084/jem.20080809
– ident: B33
  doi: 10.4049/jimmunol.0900953
– ident: B25
  doi: 10.1073/pnas.1115623109
– ident: B47
  article-title: Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
  publication-title: J Clin Invest
  contributor:
    fullname: Zhao
– ident: B61
  doi: 10.1139/o59-099
– ident: B6
  doi: 10.1158/2159-8290.CD-12-0418
– volume: 490
  start-page: 71
  year: 2011
  ident: B24
  article-title: Measuring ER stress and the unfolded protein response using mammalian tissue culture system
  publication-title: Meth Enzymol
  doi: 10.1016/B978-0-12-385114-7.00004-0
  contributor:
    fullname: Oslowski
– ident: B58
  doi: 10.1182/blood-2011-11-394346
– ident: B23
  doi: 10.1172/JCI73448
– ident: B14
  doi: 10.1016/j.molcel.2007.06.011
– ident: B37
  doi: 10.1101/gad.198630.112
– ident: B57
  doi: 10.1038/nature13119
– ident: B49
  doi: 10.1073/pnas.1217611110
– ident: B40
  doi: 10.1016/j.cell.2015.06.017
– ident: B11
  doi: 10.1371/journal.pgen.1003664
– volume: 14
  start-page: 1390
  issue: 11
  year: 2000
  ident: B2
  article-title: N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
  publication-title: Genes Dev
  doi: 10.1101/gad.14.11.1390
  contributor:
    fullname: Malynn
– ident: B29
  doi: 10.1074/jbc.M112.412783
– ident: B4
  doi: 10.1002/cmdc.200600294
– ident: B35
  doi: 10.1073/pnas.1409778111
– ident: B5
  doi: 10.1016/j.cell.2011.08.017
– ident: B32
  doi: 10.1016/j.cell.2015.05.025
– ident: B48
  doi: 10.1101/gad.198630.112
– ident: B36
  doi: 10.1073/pnas.1307237110
– ident: B54
  doi: 10.1158/2159-8290.CD-14-1507
– ident: B17
  doi: 10.1038/ng1532
– ident: B42
  doi: 10.1371/journal.pone.0033823
– ident: B30
  doi: 10.1016/j.bbrc.2015.05.061
SSID ssj0014454
Score 2.5805836
Snippet Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1300
SubjectTerms Activating transcription factor 1
Apoptosis
Biomedical research
Breast cancer
Burkitt's lymphoma
c-Myc protein
Cancer therapies
Chemotherapy
Cytotoxicity
Desaturase
Drug development
Endoplasmic reticulum
Enzymes
Fatty acids
Homeostasis
Inositol
Kinases
Lipids
Lymphoma
Metabolism
Molecular modelling
Myc protein
Neuroblastoma
Physiology
Proteins
Ribonuclease
Sensors
Therapeutic applications
Transcription factors
Tumorigenesis
Title IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers
URI https://www.ncbi.nlm.nih.gov/pubmed/29381485
https://www.proquest.com/docview/2056796800
https://search.proquest.com/docview/1993006297
https://pubmed.ncbi.nlm.nih.gov/PMC5873889
Volume 128
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTsMwEB1RFogN4k_5yUhsQ5sm7thLVIoKUivER7CLGtsRkdq0Iu2CHXfgJFyEQ3ASxmlcUdixtvMbjz1vMs_PAKcyjlFTouAZYUW1KQZ6shmjp9Gg8mn2NYufOZ077D2Ji7aVyeFuL0xB2ldxepYNhmdZ-lxwK8dDVXM8sdpNt8UFBkLIWgUqhA1dil6WDsKQl9LLviepX6k4S4G6dt26klw07Vk8FOUEZQJ8MRz9wZi_qZI_Ys_lOqyVoJGdz15uA5ZMtgkr3bIsvgWPV7dt__OD3fYoJn29vbuTbSdskI5TzZ5HQzMiGJinORsX_DuTs3xKqwT5GUsz1n1V3sRBWKOZsr7wkm_Dw2X7vtXxyhMTPEVzceKZoJ7I2NcmUVr6QotANwQlKViPTSJUPTRxqGQo-vT5mNQDxfu2rmoxDSETWvx2YDkbZWYPGBpf0mqAwkcTJhj0uQwoddQ8DhG5NFU4cYaLxjNhjKhIKLAROTtX4dBZNCqnRh41CHKhbBJQpVvMm8mpbaWin5nRNI8sq9Du7pRYhd3ZAMwf4kauCrgwNPMOVjB7sYX8qBDOLv1m_99XHsAqASZRMHcah7A8eZmaI6jkenpcOOE3-UniGA
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTuMwEB4trMRyYRd2gS4sGIlraNLEHfuIukXtQivEj9hb1NiOGommFWkP3HgHnoQX2YfgSRincbXdvXG240T-PJ5vMuPPAMcySVBToOAZYUW1yQd6spmgp9GgCsj6muXPnM419n-Ln20rk8PdWZiyaF8l2Ul-PzrJs2FZWzkZqbqrE6tf9lpcYCiErK_AR7JX33dBepU8iCJeiS8HnqSeleYsuer6r1ZXctG0t_GQnxMUC_Blh_Qfy_y3WPIv73P2-Z3f_QU2KrrJTufNm_DB5Fuw1qsS6l_hrnvVDv68sKs-ebPXp2d3J-6U3WeTTLPheGTGRCCLrGCTsnLPFKyY0f5CK5RlOes9Km_qyK_RTNlV9FB8g9uz9k2r41V3LXiKrHjqmdBPZRJokyotA6FFqBuCwhv0E5MK5UcmiZSMxICmDVM_VHxgM7KWDRGnoW1zG1bzcW52gaEJJO0jKAI0UYrhgMuQgk7NkwiRS1ODIzfh8WQuqRGXoQg2YodPDfYdEnFlVEXcILKGskmA0xCLZjIHm-MY5GY8K2Jbj2jPhUqswc4cuMVLHOI1wCVIFx2s1PZyCyFZSm5XyH1_95OH8Klz07uIL7r98z1YJ9olyvqfxj6sTh9m5gesFHp2UC7kN3mg97A
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTuNAEC2xSIgLyzBA2KaRuBrvqe4jCokIM4kQzGjmZsXdbWGJOBZODtz4B76EH-Ej-BKqHTsiww3O3V7Ur6vrlav8CuBExDEqChQszY2oNvlASzRjtBRqlC5ZX7P8mHNxg_1__LxtZHJmrb7Kon0Zp6fZ3fA0S2_L2sp8KO26Tsy-6rVCjj7nws5VYi_CMtms49WBepVACIKwEmB2LUGzK91Zctf2ZasrQt40HXnI13GKB8J5p_SBaf5fMPnOA3XWv_DuG7BW0U52Np2yCQs6-wYrvSqxvgV_u9dt9-WZXffJq70-PtW9ccfsLs1TxW5HQz0iIlmkBcvLCj5dsGJC5wztVJZmrPcgrXFNgrVi0uym--I7_Om0f7curKrngiXJmseW9p1ExK7SiVTC5Yr7yuMU5qAT64RLJ9BxIEXAB7R0mDi-DAcmM2tYEXEbOj63YSkbZXoXGGpX0HmC3EUdJOgPQuFT8KnCOEAMhW7Acb3oUT6V1ojKkAS9qMaoAQc1GlFlXEXkEWlD0SSqS7eYDZNZmFzHINOjSRGZukTzf6jABuxMwZs9pEa9ATgH62yCkdyeHyE0S-ntCr29T1_5A1auzjvRr27_5z6sEvviZRmQdwBL4_uJPoTFQk2Oyr38Bkoi-jA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IRE1%CE%B1+RNase-dependent+lipid+homeostasis+promotes+survival+in+Myc-transformed+cancers&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Xie%2C+Hong&rft.au=Tang%2C+Chih-Hang+Anthony&rft.au=Song%2C+Jun+H&rft.au=Mancuso%2C+Anthony&rft.date=2018-04-02&rft.eissn=1558-8238&rft.volume=128&rft.issue=4&rft.spage=1300&rft.epage=1316&rft_id=info:doi/10.1172%2FJCI95864&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon